Daiichi may revise open offer price for Ranbaxy
The statement assumes significance in the wake of reports that US drug major Pfizer may launch a counter offer for the non-promoter stake of Ranbaxy.
The last date for making a competitive bid, if any, has been fixed as July 7, the open offer manager